Immuron Limited

Healthcare · Biotechnology · Australia

Last price 0.92245 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 9.09M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers’ diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; ProIBS, an...